Amicus Therapeutics, Inc. (0HF9.L) LSE

8.51

+0.39(+4.80%)

Updated at October 20 07:08PM

Currency In USD

Valuation

Market Cap2.87B
Enterprise Value3.1B
P/E Ratio-68.23
PEG Ratio2.76
Price/Sales Ratio4.55
Price/Book Ratio12.72
Enterprise/Revenue5.05
Enterprise/EBITDA87.29

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.07
Operating Margin0.04

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.2

Income Statement

Revenue528.29M
Revenue/Share1.85
Gross Profit475.35M
EBITDA29.39M
Net Income-56.11M
Diluted EPS-0.18

Balance Sheet

Total Cash231M
Total Cash/Share0.75
Total Debt443.32M
Total Debt/Equity2.17
Current Ratio3.21
Book Value Per Share0.66

Price History

52-Week Change-28.79
52-Week High14.57
52-Week Low8.12
Moving Average 50 Days13.1
Moving Average 200 Days12.19

Statistics

Average Volume814
Shares Outstanding293.13M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A